✦ LIBER ✦
80* A randomised, double-blind, placebo-controlled parallel group study to investigate the safety and efficacy of two doses of tiotropium bromide (2.5 μg and 5 μg) administered once daily via the Respimat® device for 12 weeks in patients with cystic fibrosis
✍ Scribed by J.S. Elborn; A. Sharma; Q. Deng; P. Koker
- Book ID
- 118642991
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 51 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1569-1993
No coin nor oath required. For personal study only.